Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer

被引：0
|
作者：
Cengiz Beyan
Esin Beyan
机构：
[1] Ufuk University Faculty of Medicine,Department of Internal Medicine
[2] University of Health Sciences,undefined
[3] Kecioren Training and Research Hospital,undefined
来源：
International Journal of Clinical Oncology | 2020年 / 25卷
关键词：
Drug therapy; Mean platelet volume; Predictive value of tests; Prognosis; Prostatic neoplasms;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2175 / 2176
页数：1
相关论文
共 50 条
  • [1] Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer
    Beyan, Cengiz
    Beyan, Esin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (12) : 2175 - 2176
  • [2] Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer
    Yamamoto, Shimpei
    Yoshida, Soichiro
    Ishii, Chikako
    Takahara, Taro
    Arita, Yuki
    Fukushima, Hiroshi
    Tanaka, Hajime
    Yokoyama, Minato
    Matsuoka, Yoh
    Fujii, Yasuhisa
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2021, 54 (02) : 401 - 408
  • [3] The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer
    Pond, Gregory R.
    Sonpavde, Guru
    de Wit, Ronald
    Eisenberger, Mario A.
    Tannock, Ian F.
    Armstrong, Andrew J.
    EUROPEAN UROLOGY, 2014, 65 (01) : 3 - 6
  • [4] Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer
    Fukuokaya, Wataru
    Kimura, Takahiro
    Urabe, Fumihiko
    Kimura, Shoji
    Tashiro, Kojiro
    Tsuzuki, Shunsuke
    Koike, Yusuke
    Sasaki, Hiroshi
    Miki, Kenta
    Egawa, Shin
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (09) : 1695 - 1703
  • [5] Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer
    Wataru Fukuokaya
    Takahiro Kimura
    Fumihiko Urabe
    Shoji Kimura
    Kojiro Tashiro
    Shunsuke Tsuzuki
    Yusuke Koike
    Hiroshi Sasaki
    Kenta Miki
    Shin Egawa
    International Journal of Clinical Oncology, 2020, 25 : 1695 - 1703
  • [6] Serum γ-Glutamyltransferase as a Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide
    Takemura, Kosuke
    Ito, Masaya
    Nakanishi, Yasukazu
    Kataoka, Madoka
    Sakamoto, Kazumasa
    Suzuki, Hiroaki
    Tobisu, Ken-ichi
    Koga, Fumitaka
    ANTICANCER RESEARCH, 2019, 39 (10) : 5773 - 5780
  • [7] Mean platelet volume may not be an independent prognostic factor in breast cancer patients with type 2 diabetes mellitus
    Beyan, Cengiz
    Beyan, Esin
    BREAST CANCER, 2019, 26 (06) : 852 - 853
  • [8] Mean platelet volume may not be an independent prognostic factor in breast cancer patients with type 2 diabetes mellitus
    Cengiz Beyan
    Esin Beyan
    Breast Cancer, 2019, 26 : 852 - 853
  • [9] Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy
    Linton, Anthony
    Pond, Greg
    Clarke, Stephen
    Vardy, Janette
    Galsky, Matthew
    Sonpavde, Guru
    CLINICAL GENITOURINARY CANCER, 2013, 11 (04) : 423 - 430
  • [10] Serum prolactin level as a predictive factor for abiraterone response in patients with metastatic castration-resistant prostate cancer
    Yang, Tao
    Liu, Ying
    Chen, Shuzhen
    Tian, Jiale
    Zhu, Xuyou
    Zhang, Long
    Wang, Wei
    Qin, Yingyi
    Richter, Jens
    Anand, Aseem
    Xu, Chengdang
    Chi, Yongnan
    Wang, Chenyang
    Bian, Cuidong
    Wu, Denglong
    Li, Zhenfei
    Huang, Shengsong
    PROSTATE, 2022, 82 (13) : 1284 - 1292
12345